Artiva Biotherapeutics Inc (NASDAQ:ARTV) shares, rose in value on Wednesday, June 18, with the stock price down by -6.67% to the previous day’s close as strong demand from buyers drove the stock to $1.68.
Actively observing the price movement in the last trading, the stock closed the session at $1.80, falling within a range of $1.6705 and $1.9. Referring to stock’s 52-week performance, its high was $17.31, and the low was $1.78. On the whole, ARTV has fluctuated by -16.83% over the past month.
With the market capitalization of Artiva Biotherapeutics Inc currently standing at about $40.93 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ARTV’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of ARTV currently trading nearly -14.72% and -20.07% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 35.17, while the 7-day volatility ratio is showing 5.70% which for the 30-day chart, stands at 4.71%. Furthermore, Artiva Biotherapeutics Inc (ARTV)’s average true range (ATR) is 0.19.
Data on historical trading for Artiva Biotherapeutics Inc (NASDAQ:ARTV) indicates that the trading volumes over the past 10 days have averaged 0.17 and over the past 3 months, they’ve averaged 323.24K. According to company’s latest data on outstanding shares, there are 24.36 million shares outstanding.
Nearly 49.52% of Artiva Biotherapeutics Inc’s shares belong to company insiders and institutional investors own 63.60% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.28 million shares as on 2025-05-30, resulting in a short ratio of 8.92. According to the data, the short interest in Artiva Biotherapeutics Inc (ARTV) stood at 1311.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 1.46 million. The stock has fallen by -83.33% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ARTV stock heading into the next quarter.
